Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Net Income (Discontinued Operations) : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Rapid Therapeutic Science Laboratories Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Rapid Therapeutic Science Laboratories's Net Income (Discontinued Operations) for the three months ended in Jun. 2023 was $0.00 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Rapid Therapeutic Science Laboratories Net Income (Discontinued Operations) Historical Data

The historical data trend for Rapid Therapeutic Science Laboratories's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Therapeutic Science Laboratories Net Income (Discontinued Operations) Chart

Rapid Therapeutic Science Laboratories Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Net Income (Discontinued Operations)

Get a 7-Day Free Trial

Rapid Therapeutic Science Laboratories Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Net Income (Discontinued Operations)	Get a 7-Day Free Trial															-	-	-	-	-

Rapid Therapeutic Science Laboratories Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Rapid Therapeutic Science Laboratories Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Rapid Therapeutic Science Laboratories's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Therapeutic Science Laboratories Inc (OTCPK:RTSL) » Definitions » Net Income (Discontinued Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

5580 Peterson Lane, Suite 120, Dallas, TX, USA, 75201

Website

https://www.rtslco.com

Rapid Therapeutic Science Laboratories Inc is a biotech company specializing in natural-based relief through aerosol delivery of cannabinoids to the systemic bloodstream through the pulmonary route of administration. The company manufactures its own branded metered dose inhalers (MDI) under the nhaler name using proprietary blends of pure cannabinoids such as cannabidiol (CBD) and cannabigerol (CBG). In addition, the company manufactures other aerosol devices for the delivery of cannabinoids other than MDI such as sublingual sprays.

Executives

Henry Anthony Punzi	director	1932 WALNUT PLAZA, CARROLLTON TX 75006
Scott Suggs Justin	director	639 SWORD BRIDGE DR., LEWISVILLE TX 75056
Sean Paul Berrier	10 percent owner	7108 DUFFIELD DR., DALLAS TX 75248
Schmidt Donal Ray Jr.	director, 10 percent owner, officer: President and CEO	5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
Ryan Casey Johnson	director, officer: Chief Operating Officer	2307 CASTLE ROCK RD, CARROLTON TX 75007
Texas Mdi, Inc.	10 percent owner	5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
D Hughes Watler	director, officer: CFO	2323 S. VOSS ROAD, STE. 510-12, HOUSTON TX 77057
Steve Bond	director, officer: CFO	28839 PUJOL ST., #832, TEMECULA CA 92590
Brent Willson	director, officer: CEO and President	5271 CAMINITO EXQUISITO, SAN DIEGO CA 92130